Nigral transcriptomic profiles in Engrailed-1 hemizygous mouse models of Parkinson's disease reveal upregulation of oxidative phosphorylation-related genes associated with delayed dopaminergic neurodegeneration.

Parkinson’s disease genetic susceptibility mitochondria neurodegeneration substantia nigra transcriptomics

Journal

Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824

Informations de publication

Date de publication:
2024
Historique:
received: 12 11 2023
accepted: 18 01 2024
medline: 20 2 2024
pubmed: 20 2 2024
entrez: 20 2 2024
Statut: epublish

Résumé

Parkinson's disease (PD) is the second most common neurodegenerative disorder, increasing both in terms of prevalence and incidence. To date, only symptomatic treatment is available, highlighting the need to increase knowledge on disease etiology in order to develop new therapeutic strategies. Hemizygosity for the gene Engrailed-1 ( Transcriptome profiles were defined by RNAseq in microdissected substantia nigra from 1-week old OF1, OF1- Nigrostriatal neurodegeneration was manifested in OF1- Our results suggest that increased expression of genes encoding mitochondrial proteins before the onset of neurodegeneration is associated with increased resistance to PD-like nigrostriatal neurodegeneration. This highlights the importance of genetic background in PD models, how different strains can be used to model clinical and sub-clinical pathologies and provides insights to gene expression mechanisms associated with PD susceptibility and progression.

Identifiants

pubmed: 38374883
doi: 10.3389/fnagi.2024.1337365
pmc: PMC10875038
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1337365

Informations de copyright

Copyright © 2024 Belfiori, Dueñas Rey, Ralbovszki, Jimenez-Ferrer, Fredlund, Balikai, Ahrén, Brolin and Swanberg.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Lautaro Francisco Belfiori (LF)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

Alfredo Dueñas Rey (A)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Dorottya Mária Ralbovszki (DM)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

Itzia Jimenez-Ferrer (I)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

Filip Fredlund (F)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

Sagar Shivayogi Balikai (SS)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

Dag Ahrén (D)

Department of Biology, National Bioinformatics Infrastructure Sweden (NBIS), SciLifeLab, Stockholm, Sweden.

Kajsa Atterling Brolin (KA)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

Maria Swanberg (M)

Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Sciences, Lund University, Lund, Sweden.

Classifications MeSH